policy+practice

Allergan Chairman and Chief Executive Officer Brent Saunders talks about how he built up the pharmaceutical giant, the pending sale of Allergan to Abbvie, why he took a huge pay cut to come to Allergan, and the controversial subject of drug pricing.

Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable.

Malaysian Health Minister Dzulkefly Ahmad says his ministry is still discussing the control of drug prices at private hospitals and clinics with the relevant stakeholders.

There is no shortage of good intentions and even better ideas on how to bring sanity to the overwhelming complexity of rising drug prices — and doing so without blocking the pipeline of life-saving new drugs.

There is no best-case drug pricing scenario for the drug industry in 2020.

Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market.

The financial impact of discount cards that drug companies promote.

UK's NHS is already for sale – 18% of NHS funding now goes to private providers including Virgin Care.

Amid intense political debate, studies have reached drastically different conclusions about a single-payer system’s price tag, cost to families and effect on the health system.

The Department of Health (DOH) will draft an executive order that will recommend bringing down the prices of high-cost medicines.

President Trump’s top health care adviser called Speaker Pelosi’s plan to lower drug prices “unworkable” while endorsing a bipartisan bill in the Senate. 

Researchers familiar with the field say CDC researchers did not invent the concept underpinning PrEP —that the same antiretroviral drugs (ARVs) used to treat HIV could, like malarial pills given to travelers, works as preventives.

A Look at the Trump Administration’s Pharmaceutical Pricing Policy Proposals

In response to rising drug prices, states are working to take coordinated action across public purchasers.

A pair of bipartisan measures to lower drug prices were thrown off track Thursday by objections as senators battle over the issue.